CONNECT WITH US:
Feb, 07 2019 09:00 JST
Lubrizol LifeSciences to Showcase New Medical Device Applications Lab at MDM West 2019
CLEVELAND, Ohio, Feb, 07 2019 - (ACN Newswire) - The Lubrizol Corporation announces its LifeSciences business will feature a new medical device applications lab. LifeSciences has invested significantly to expand its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio. This lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time.
The medical device applications lab is yet another substantial piece of LifeSciences' full-service capabilities. These capabilities and more will be on display at the MD&M West Exposition (Booth #2401), February 5-7. Lubrizol LifeSciences is a preferred medical device development partner, helping customers from concept to commercialization by offering polymer customization, drug-eluting device development and contract manufacturing services. At MD&M, LifeSciences will also highlight a strong presence in the interventional catheter, long-term implant and drug-eluting device markets. In addition, LifeSciences will unveil new dexamethasone-loaded polymers designed to minimize inflammation and help ensure the success of implantable medical devices.
"The new applications lab is another commitment to healthcare companies looking for a full-service development partner. We continue to invest in the right areas to provide valuable offerings where our customers are experiencing the most growth," states Uwe Winzen, general manager, Lubrizol LifeSciences. "When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process."
Offering more than 90 years of science and technology experience, Lubrizol is uniquely structured to partner with medical device manufacturers by providing proactive innovation, speed to market, and expertise for the most demanding projects. From materials to development and manufacturing, or anything in between - Lubrizol LifeSciences is equipped to support the needs of customers worldwide.
About Lubrizol LifeSciences
Lubrizol LifeSciences is a preferred Contract Development and Manufacturing Organization (CDMO) partner for complex pharmaceuticals and high-end medical devices providing differentiated polymers and excipients, along with state-of-the-art design, development and manufacturing services to the healthcare industry.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2017 were $6.3 billion. For more information, visit Lubrizol.com.
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Lubrizol to Feature New Bio TPU Grades for 3D Printing and Molded Parts at Plastteknik Fair 2019
April 18 2019 07:30 JST
Lubrizol is Ready for ILSAC GF-6 - Announcing Lubrizol(R) PV1510 Additive Technology for the GF-6 Specification
April 16 2019 07:00 JST
Lubrizol Showcases Renewable-Sourced Estane(R) 3D ECO TPU for 3D Printing at RAPID + TCT 2019
April 12 2019 20:30 JST
Lubrizol Introduces Carbopol Style 2.0 polymer
April 03 2019 20:30 JST
Lubrizol Announces Collaboration with CP Kelco
March 29 2019 15:00 JST
Lubrizol Expands Pearlbond Toluene-free TPU Portfolio For Adhesive Films, Powder & Webs
March 26 2019 20:30 JST
Lubrizol to Participate at In-Cosmetics Global, Paris
March 26 2019 20:00 JST
Particle Sciences Invests in Commercialization Expertise
March 26 2019 09:00 JST
Lubrizol Engineered Polymers Signs Agreement with The Institute of Chemical Technology in India
March 25 2019 09:00 JST
Lubrizol Completes Acquisition of Laboratoire Phenobio
March 18 2019 22:00 JST
More Press release >>
Latest Press Release
Toyota: The Future of Zero-Emission Trucking Takes Another Leap Forward
Apr 23, 2019 09:00 JST
Mitsubishi Shipbuilding Holds Christening Ceremony for Next-Generation LNG Carrier "Diamond Gas Sakura"
Apr 22, 2019 15:10 JST
Network International and JCB enable JCB Contactless acceptance in the United Arab Emirates
Apr 22, 2019 15:00 JST
Toyota Establishes Joint Research Institute with China's Tsinghua University
Apr 22, 2019 11:20 JST
Fujitsu to Introduce Sustainable Ingredients to Employee Cafeterias on Ongoing Basis
Apr 22, 2019 11:08 JST
TOYOTA GAZOO Racing Eyes South American Gravel Glory
Apr 19, 2019 17:30 JST
Toyota, DENSO and SoftBank Vision Fund to Invest $1 Billion in Uber's Advanced Technologies Group
Apr 19, 2019 09:35 JST
DOCOMO, DOCOMO USA and ITOCHU Logistics to trial IoT Fleet Management solution in US
Apr 18, 2019 16:52 JST
MHI Thermal Systems Develops Demonstration Unit of the World's First Small-Capacity Residential Air-Conditioner Adopting the Low-GWP R454C Refrigerant
Apr 18, 2019 14:38 JST
Fujitsu to Hold Fujitsu Forum 2019
Apr 18, 2019 11:57 JST
Mazda Announces Start of US Pre-Orders for Diesel-Powered Mazda CX-5 at New York International Auto Show
Apr 18, 2019 11:30 JST
Nagasaki University and NEC Establish Program on Global Health & Biometric Authentication
Apr 18, 2019 09:36 JST
World Premiere of Toyota's All-New 2020 Highlander at New York International Auto Show
Apr 17, 2019 13:04 JST
Honda Exhibits the World Premiere of the X-NV Concept at Auto Shanghai 2019
Apr 16, 2019 14:54 JST
MHI Machine Tool Completes Commercial Model of Metal 3D Printer Using Laser Beams
Apr 16, 2019 13:44 JST
SDK Group Starts Mass Production of Liquefied Carbon Dioxide in Oita Petrochemical Complex
Apr 16, 2019 12:00 JST
Toyota Premieres Toyota-brand Battery Electric Vehicles Ahead of 2020 China Launch
Apr 16, 2019 11:25 JST
Fujitsu Sets Out the 'Fujitsu Technology and Service Vision 2019'
Apr 16, 2019 11:11 JST
AMADA to Construct Main Production Facilities in Japan through Collaborative Creation with Hitachi
Apr 16, 2019 08:25 JST
Fujitsu Begins Production of Post-K
Apr 15, 2019 11:17 JST
More Latest Release >>